Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiro Yasunaga

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Seminars in Cancer Biology|June 11, 2019
Antibody therapeutics and immunoregulation in cancer and autoimmune diseaseMasahiro Yasunaga
Scientific Reports|May 1, 2014
Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancerMasahiro Yasunaga, Yasuhiro Matsumura
Methods in Molecular Biology (Clifton, N.J.)|May 10, 2026
Laboratory-Scale Production of Recombinant IgG AntibodiesTakahiro Anzai, Masahiro Yasunaga
Methods in Molecular Biology (Clifton, N.J.)|May 10, 2026
Advanced Evaluation of T-Cell-Dependent Bispecific Antibodies Using Fluorescence Imaging and In Vivo ModelsMikiko Itsukaichi, Masahiro Yasunaga
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|January 19, 2007
[Production of endoderm-derived visceral organ cells from ES cells]Masahiro Yasunaga, Shin-Ichi Nisikawa
Cancer Science|April 13, 2011
New concept of cytotoxic immunoconjugate therapy targeting cancer-induced fibrin clotsMasahiro Yasunaga, Shino Manabe, Yasuhiro Matsumura
Methods in Molecular Biology (Clifton, N.J.)|May 10, 2026
Optimized In Vitro T-Cell Exhaustion Assay for Evaluating T-Cell-Dependent Bispecific AntibodiesMayu Oka, Mikiko Itsukaichi, Masahiro Yasunaga
Scientific Reports|September 8, 2017
Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune diseaseMasahiro Yasunaga, Shino Manabe, Yasuhiro Matsumura
Methods in Molecular Biology (Clifton, N.J.)|May 10, 2026
Fluorescent-Based Analysis of T Cells and T-Cell-Dependent Bispecific Antibody in a Brain Tumor Mouse ModelYuri Nakamura, Teppei Azuma, Masahiro Yasunaga
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor ImmunityDaisuke Kamakura, Ryutaro Asano, Masahiro Yasunaga
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Seminars in Cancer Biology|June 11, 2019
Antibody therapeutics and immunoregulation in cancer and autoimmune diseaseMasahiro Yasunaga
Scientific Reports|May 1, 2014
Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancerMasahiro Yasunaga, Yasuhiro Matsumura
Methods in Molecular Biology (Clifton, N.J.)|May 10, 2026
Laboratory-Scale Production of Recombinant IgG AntibodiesTakahiro Anzai, Masahiro Yasunaga
Methods in Molecular Biology (Clifton, N.J.)|May 10, 2026
Advanced Evaluation of T-Cell-Dependent Bispecific Antibodies Using Fluorescence Imaging and In Vivo ModelsMikiko Itsukaichi, Masahiro Yasunaga
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|January 19, 2007
[Production of endoderm-derived visceral organ cells from ES cells]Masahiro Yasunaga, Shin-Ichi Nisikawa
Cancer Science|April 13, 2011
New concept of cytotoxic immunoconjugate therapy targeting cancer-induced fibrin clotsMasahiro Yasunaga, Shino Manabe, Yasuhiro Matsumura
Methods in Molecular Biology (Clifton, N.J.)|May 10, 2026
Optimized In Vitro T-Cell Exhaustion Assay for Evaluating T-Cell-Dependent Bispecific AntibodiesMayu Oka, Mikiko Itsukaichi, Masahiro Yasunaga
Scientific Reports|September 8, 2017
Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune diseaseMasahiro Yasunaga, Shino Manabe, Yasuhiro Matsumura
Methods in Molecular Biology (Clifton, N.J.)|May 10, 2026
Fluorescent-Based Analysis of T Cells and T-Cell-Dependent Bispecific Antibody in a Brain Tumor Mouse ModelYuri Nakamura, Teppei Azuma, Masahiro Yasunaga
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor ImmunityDaisuke Kamakura, Ryutaro Asano, Masahiro Yasunaga
Pageof 10